These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


233 related items for PubMed ID: 28277784

  • 1. Association Between MTHFR C677T Polymorphism and Methotrexate Treatment Outcome in Rheumatoid Arthritis Patients: A Systematic Review and Meta-Analysis.
    Shao W, Yuan Y, Li Y.
    Genet Test Mol Biomarkers; 2017 May; 21(5):275-285. PubMed ID: 28277784
    [Abstract] [Full Text] [Related]

  • 2. Association of the MTHFR C677T and A1298C polymorphisms with methotrexate toxicity in rheumatoid arthritis: a meta-analysis.
    Song GG, Bae SC, Lee YH.
    Clin Rheumatol; 2014 Dec; 33(12):1715-24. PubMed ID: 24794492
    [Abstract] [Full Text] [Related]

  • 3. Pharmacogenetic polymorphisms contributing to toxicity induced by methotrexate in the southern Spanish population with rheumatoid arthritis.
    Plaza-Plaza JC, Aguilera M, Cañadas-Garre M, Chemello C, González-Utrilla A, Faus Dader MJ, Calleja MA.
    OMICS; 2012 Nov; 16(11):589-95. PubMed ID: 23095111
    [Abstract] [Full Text] [Related]

  • 4. Correlation between methotrexate efficacy & toxicity with C677T polymorphism of the methylenetetrahydrofolate gene in rheumatoid arthritis patients on folate supplementation.
    Aggarwal P, Naik S, Mishra KP, Aggarwal A, Misra R.
    Indian J Med Res; 2006 Nov; 124(5):521-6. PubMed ID: 17213520
    [Abstract] [Full Text] [Related]

  • 5. The C677T polymorphism in the MTHFR gene is associated with the toxicity of methotrexate in a Spanish rheumatoid arthritis population.
    Cáliz R, del Amo J, Balsa A, Blanco F, Silva L, Sanmarti R, Martínez FG, Collado MD, Ramirez Mdel C, Tejedor D, Artieda M, Pascual-Salcedo D, Oreiro N, Andreu JL, Graell E, Simon L, Martínez A, Mulero J.
    Scand J Rheumatol; 2012 Feb; 41(1):10-4. PubMed ID: 22044028
    [Abstract] [Full Text] [Related]

  • 6. Are Thymidylate synthase and Methylene tetrahydrofolate reductase genes linked with methotrexate response (efficacy, toxicity) in Indian (Asian) rheumatoid arthritis patients?
    Ghodke Y, Chopra A, Joshi K, Patwardhan B.
    Clin Rheumatol; 2008 Jun; 27(6):787-9. PubMed ID: 18274813
    [Abstract] [Full Text] [Related]

  • 7. Lack of association between MTHFR A1298C polymorphism and outcome of methotrexate treatment in rheumatoid arthritis patients: evidence from a systematic review and meta-analysis.
    Fan H, Li Y, Zhang L, Li Y, Li W.
    Int J Rheum Dis; 2017 May; 20(5):526-540. PubMed ID: 28544525
    [Abstract] [Full Text] [Related]

  • 8. Genetic Determinants of Methotrexate Toxicity in Tunisian Patients with Rheumatoid Arthritis: A Study of Polymorphisms Involved in the MTX Metabolic Pathway.
    Chaabane S, Marzouk S, Akrout R, Ben Hamad M, Achour Y, Rebai A, Keskes L, Fourati H, Bahloul Z, Maalej A.
    Eur J Drug Metab Pharmacokinet; 2016 Aug; 41(4):385-93. PubMed ID: 26077125
    [Abstract] [Full Text] [Related]

  • 9. Association of MTHFR and RFC1 gene polymorphisms with methotrexate efficacy and toxicity in Chinese Han patients with rheumatoid arthritis.
    Wang S, Zuo S, Liu Z, Ji X, Yao Z, Wang X.
    J Int Med Res; 2020 Feb; 48(2):300060519879588. PubMed ID: 31617429
    [Abstract] [Full Text] [Related]

  • 10. The impact of C677T and A1298C MTHFR polymorphisms on methotrexate therapeutic response in East Bohemian region rheumatoid arthritis patients.
    Soukup T, Dosedel M, Pavek P, Nekvindova J, Barvik I, Bubancova I, Bradna P, Kubena AA, Carazo AF, Veleta T, Vlcek J.
    Rheumatol Int; 2015 Jul; 35(7):1149-61. PubMed ID: 25618758
    [Abstract] [Full Text] [Related]

  • 11. Associations between the C677T and A1298C polymorphisms of MTHFR and the efficacy and toxicity of methotrexate in rheumatoid arthritis: a meta-analysis.
    Lee YH, Song GG.
    Clin Drug Investig; 2010 Jul; 30(2):101-8. PubMed ID: 20067328
    [Abstract] [Full Text] [Related]

  • 12. Methylenetetrahydrofolate reductase polymorphisms, C677T and A1298C, are associated with methotrexate-related toxicities in Korean patients with rheumatoid arthritis.
    Choe JY, Lee H, Jung HY, Park SH, Bae SC, Kim SK.
    Rheumatol Int; 2012 Jun; 32(6):1837-42. PubMed ID: 21773884
    [Abstract] [Full Text] [Related]

  • 13. Methylene tetrahydrofolate reductase genotypes frequencies: association with toxicity and response to methotrexate in rheumatoid arthritis patients.
    Saleh MM, Irshaid YM, Mustafa KN.
    Int J Clin Pharmacol Ther; 2015 Feb; 53(2):154-62. PubMed ID: 25492850
    [Abstract] [Full Text] [Related]

  • 14. Associations between C677T and A1298C polymorphisms of MTHFR and susceptibility to rheumatoid arthritis: a systematic review and meta-analysis.
    Yuan Y, Shao W, Li Y.
    Rheumatol Int; 2017 Apr; 37(4):557-569. PubMed ID: 28175955
    [Abstract] [Full Text] [Related]

  • 15. Methylenetetrahydrofolate reductase polymorphisms and methotrexate: no association with response to therapy nor with drug-related adverse events in an Italian population of rheumatic patients.
    Taraborelli M, Andreoli L, Archetti S, Ferrari M, Cattaneo R, Tincani A.
    Clin Exp Rheumatol; 2009 Apr; 27(3):499-502. PubMed ID: 19604445
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and toxicity of methotrexate in early rheumatoid arthritis are associated with single-nucleotide polymorphisms in genes coding for folate pathway enzymes.
    Wessels JA, de Vries-Bouwstra JK, Heijmans BT, Slagboom PE, Goekoop-Ruiterman YP, Allaart CF, Kerstens PJ, van Zeben D, Breedveld FC, Dijkmans BA, Huizinga TW, Guchelaar HJ.
    Arthritis Rheum; 2006 Apr; 54(4):1087-95. PubMed ID: 16572443
    [Abstract] [Full Text] [Related]

  • 17. Methotrexate (MTX) pathway gene polymorphisms and their effects on MTX toxicity in Caucasian and African American patients with rheumatoid arthritis.
    Ranganathan P, Culverhouse R, Marsh S, Mody A, Scott-Horton TJ, Brasington R, Joseph A, Reddy V, Eisen S, McLeod HL.
    J Rheumatol; 2008 Apr; 35(4):572-9. PubMed ID: 18381794
    [Abstract] [Full Text] [Related]

  • 18. Influence of MTHFR C677T polymorphism on methotrexate monotherapy discontinuation in rheumatoid arthritis patients: results from the GAPAID European project.
    Uribarri M, Ruiz-Larrañaga O, Arteta D, Hernández L, Alcaro MC, Martínez A, Escorza-Treviño S, Estonba A, Migliorini P, Czirják L, del Amo J.
    Clin Exp Rheumatol; 2015 Apr; 33(5):699-705. PubMed ID: 26314492
    [Abstract] [Full Text] [Related]

  • 19. Associations between methotrexate treatment and methylenetetrahydrofolate reductase gene polymorphisms with incident fractures in Japanese female rheumatoid arthritis patients.
    Urano W, Furuya T, Inoue E, Taniguchi A, Urano T, Kotake S, Sekita C, Inoue S, Hara M, Momohara S, Kamatani N, Yamanaka H.
    J Bone Miner Metab; 2009 Apr; 27(5):574-83. PubMed ID: 19333678
    [Abstract] [Full Text] [Related]

  • 20. Homocysteine and folate status in methotrexate-treated patients with rheumatoid arthritis.
    van Ede AE, Laan RF, Blom HJ, Boers GH, Haagsma CJ, Thomas CM, De Boo TM, van de Putte LB.
    Rheumatology (Oxford); 2002 Jun; 41(6):658-65. PubMed ID: 12048292
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.